The essential guide to controlling and managing today’s communicable diseases
The fourth edition of Communicable Disease Control and Health Protection Handbook offers public health workers of all kinds an authoritative and up-to-date guide to current protocols surrounding the identification and control of infectious diseases. With its concise, accessible design, the book is a practical tool that can be relied upon to explain topics ranging from the basic principles of communicable disease control to recent changes and innovations in health protection practice. Major syndromes and individual infections are insightfully addressed, while the authors also outline the WHO’s international health regulations and the organizational arrangements in place in all EU nations.
New to the fourth edition are chapters on Ebola, the Zika virus, and other emerging pandemics. In addition, new writing on healthcare-associated infection, migrant and refugee health, and the importance of preparedness make this an essential and relevant text for all those in the field. This vital resource:
Reflects recent developments in the science and administration of health protection practice
Covers topics such as major syndromes, control of individual infections, main services and activities, arrangements for all European countries, and much more
Includes new chapters on the Zika virus, Schistosomiasis, Coronavirus including MERS + SARS, and Ebola
Follows a format designed for ease of use and everyday consultation
Created to provide public and environmental health practitioners, physicians, epidemiologists, infection control nurses, microbiologists and trainees with a straightforward – yet informative – resource, Communicable Disease Control and Health Protection Handbook is a practical companion for all those working the field today.
CONTENTS
Section 1: Introduction
1. How to use this book
2. Basic concepts in epidemiology of infectious disease
3. Basic concepts in the prevention of infection
4. Emergency risk communication
5. Basic principles of on-call
Section 2: Common Topics
1. Meningitis and meningism
2. Gastrointestinal infection
3. Community acquired pneumonia
4. Rash in pregnancy
5. Rash and fever in children
6. Illness in returning travellers
7. Jaundice
8. Infection in the immunosuppressed
Section 3: Diseases
1. Amoebic dysentery
2. Anthrax
3. Bacillus cereus
4. Botulism
5. Brucellosis
6. Campylobacter
7. Chickenpox and shingles
8. Chikungunya
9. Chlamydia pneumoniae
10. Chlamydia trachomatis
11. Cholera
12. CJD and other Human TSEs
13. Clostridium difficile
14. Clostridium perfringens
15. Coronavirus (including MERS and SARS)
16. Cryptosporidiosis
17. Cyclosporiasis
18. Cytomegalovirus
19. Dengue fever
20. Diphtheria
21. Enterococci (including GRE)
22. Enterovirus infections (including hand, foot and mouth disease)
23. Epstein-Barr virus
24. Giardiasis
25. Gram-negative bacteraemias (including Carbapenem resistant enterobacteriaceae)
26. Gonorrhoea, syphilis and other acute STIs
27. Hantavirus
28. Headlice
29. Helicobacter pylori
30. Hepatitis A
31. Hepatitis B
32. Hepatitis C
33. Hepatitis, delta
34. Hepatitis E
35. Herpes simplex
36. Haemophilus influenza type b (Hib)
37. HIV
38. Influenza
39. Japanese B encephalitis
40. Legionellosis
41. Leprosy
42. Leptospirosis
43. Listeriosis
44. Lyme disease
45. Malaria
46. Measles
47. Meningococcal infection
48. MRSA
49. Mumps
50. Mycoplasma pneumoniae infection
51. Norovirus
52. Paratyphoid fever
53. Parvovirus B19 (fifth disease)
54. Plague
55. Pneumococcal infection
56. Poliomyelitis
57. Psittacosis
58. Q fever
59. Rabies
60. Relapsing fever
61. Respiratory syncytial virus (RSV)
62. Ringworm
63. Rotavirus
64. Rubella
65. Salmonellosis
66. Scabies
67. Schistosomiasis
68. Shigellosis
69. Shiga-toxin producing E. coli (STEC) and other diarrhoeagenic E. coli
70. Smallpox
71. Staphylococcal food poisoning
72. Streptococcal infections
73. Tetanus
74. Threadworms
75. Tick-borne encephalitis
76. Toxocariasis
77. Toxoplasmosis
78. Tuberculosis (and non-tuberculous mycobacteria)
79. Tularaemia
80. Typhoid fever
81. Vibrio parahaemolyticus
82. Viral haemorrhagic fevers (including Ebola)
83. Warts & verrucae (and Molluscum contagiosum)
84. West Nile virus
85. Whooping cough (pertussis)
86. Yellow fever
87. Yersiniosis
88. Zika virus
89. Other organisms
1. Bacteria
2. Rickettsia
3. Viruses
4. Protozoa
5. Helminths
6. Fungi
7. Bites, stings and venoms
8. Chemical food-borne illness
Section 4: Services and Organisations
1. Surveillance of Communicable Disease
2. Managing infectious disease incidents and outbreaks
3. Community infection control
4. Hospital infection control
5. Antimicrobial stewardship
6. Risks to & from healthcare workers
7. Co-ordination if immunisation services
8. Co-ordination of sexual health services
9. Prevention of blood-borne viral infection
10. Co-ordination of services for tuberculosis control
11. Travel Health
12. Migrant and refugee health
13. Emergency preparedness planning and response
14. Non-infectious environmental hazards
15. Managing acute chemical incidents
16. Managing acute radiation incidents
17. Deliberate release of biological, chemical or radiological hazards
18. Clinical governance and audit
19. Global health security
Section 5: Communicable Disease Control in Europe
1. WHO and the International Health Regulations
2. International collaboration in Europe
3. National Example: Administrative arrangements for health protection in England
4. Austria
5. Belgium
6. Bulgaria
7. Croatia
8. Cyprus
9. Czech Republic
10. Denmark
11. Estonia
12. Finland
13. France
14. Germany
15. Greece
16. Hungary
17. Iceland
18. Republic of Ireland
19. Italy
20. Latvia
21. Lithuania
22. Luxemburg
23. Malta
24. Netherlands
25. Norway
26. Poland
27. Portugal
28. Romania
29. Slovakia
30. Slovenia
31. Spain
32. Sweden
33. Switzerland
34. United Kingdom
Appendix: Guidance documents
Other useful websites
Jeremy Hawker is Consultant Epidemiologist in the Field Service of Public Health England’s National Infection Service and honorary Professor at the Universities of Liverpool, Warwick and Staffordshire. Norman Begg is an independent vaccine consultant who has worked in public health and the pharmaceutical industry and former Chief Medical Officer, GlaxoSmithKline Biologicals, Wavre, Belgium. Ralf Reintjes is Professor of Epidemiology and Public Health Surveillance, Hamburg, Germany and Adjunct Professor of Infectious Disease Epidemiology, Tampere, Finland. Karl Ekdahl is Head of Public Health Capacity and Communication Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Obaghe Edeghere is Consultant Epidemiologist for the Field Service of Public Health England’s National Infection Service, UK. Jim van Steenbergen is an an independent consultant in communicable disease control and former National Coordinator for Communicable Disease Control, Centre for Infectious Disease Control at the National Institute for Public Health and the Environment, Netherlands
Onze klantenservice staat voor je klaar. Raadpleeg onze veelgestelde vragen of neem contact op.
Registreer je om een Acco-aandeel aan te kopen of te koppelen en geniet meteen van korting. Inloggen/registreren is ook nodig om bepaalde bestanden te downloaden.
Registreer